Profile
Laurel A.
Omert served as Chief Medical Officer of Northfield Laboratories, Inc. from January 2005 to May 5, 2009.
She was an Associate Director of Trauma at Allegheny General Hospital.
Dr. Omert was an Associate Professor of Surgery at Drexel University.
She was an Associate Professor of Surgery and Director of Trauma at West Virginia University.
Dr. Omert received a BA from Yale University and an MD from Loyola University.
Former positions of Laurel A. Omert
| Companies | Position | End |
|---|---|---|
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Chief Tech/Sci/R&D Officer | 07/05/2009 |
| Drexel University | Corporate Officer/Principal | 09/01/2005 |
Allegheny General Hospital, Inc.
 Allegheny General Hospital, Inc. Hospital/Nursing ManagementHealth Services Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA. | Corporate Officer/Principal | 31/12/2004 |
| West Virginia University | Corporate Officer/Principal | - |
Training of Laurel A. Omert
| Yale University | Undergraduate Degree |
| Loyola University New Orleans | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
Allegheny General Hospital, Inc.
Allegheny General Hospital, Inc. Hospital/Nursing ManagementHealth Services Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA. | Health Services |
- Stock Market
- Insiders
- Laurel A. Omert
